Penumbra (PEN) Stock Price
$291.7 0%
to add to portfolio
AI Score

-
Alternative
6 -
Fundamental
8 -
Technical
9
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Penumbra, AI stock picks, stock alerts and much more.
PEN AI Stock Analysis
AI stock analysis for PEN is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Penumbra (PEN) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Penumbra (PEN) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Penumbra (PEN), currently trading at $291.7, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About PEN

-
Penumbra, Inc.
-
Symbol
PEN
-
Market
NYSE
-
Industry
Medical - Devices
-
Market Cap
11.2B
Similar Stocks
![]() |
Abbott Laboratories ABT |
$134.9 1.3% |
7 |
![]() |
Boston Scientific BSX |
$104.5 0.8% |
7 |
![]() |
Edwards Lifesciences EW |
$73.3 1.9% |
6 |
![]() |
Medtronic MDT |
$89.94 2.3% |
7 |
![]() |
Stryker SYK |
$382.8 0.9% |
7 |
News
PEN Alternative Data
Web Traffic
Penumbra receives an estimated 30004 monthly visitors to penumbrainc.com.
-
Web Traffic
30004
-
Change from Previous Month
8.7%
-
3 Month Change
13%
-
YoY Change
13%
News Mentions
Penumbra was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
50%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
Penumbra has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
Facebook Engagement
Penumbra has engaged 9 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
9
-
Daily Change
0%
-
1 Month Change
57.1%
-
3 Month Change
72.7%
-
YoY Change
72.7%
Youtube Subscribers
Penumbra has 3,860 subscribers on its main Youtube channel, up by 0.5% over the last month.
-
Youtube Subscribers
3860
-
Daily Change
0%
-
1 Month Change
0.5%
-
3 Month Change
1.6%
-
YoY Change
1.6%
LinkedIn Followers
57,438 are following Penumbra on LinkedIn, up by 2.1% over the last month.
-
LinkedIn Followers
57438
-
Daily Change
0%
-
1 Month Change
2.1%
-
3 Month Change
5.2%
Job Postings
Penumbra has an estimated 48 open job postings, which is down -28.4% over the last month.
-
Job Postings
48
-
Daily Change
0%
-
1 Month Change
28.4%
-
3 Month Change
29.4%
-
YoY Change
29.4%
LinkedIn Employees
According to LinkedIn, Penumbra has 2,677 employees, up by 1.2% over the last month.
-
LinkedIn Employees
2677
-
Daily Change
0%
-
1 Month Change
1.2%
-
3 Month Change
1.9%
-
YoY Change
1.9%
Twitter Followers
Penumbra has 4,123 Twitter Followers on its main Twitter (also known as X) account, which is down by -0% over the last month.
-
Twitter Followers
4123
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0.5%
-
YoY Change
0.5%
Business Outlook
-
Business Outlook
57
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
PEN Financials
PEN Key Metrics
-
Total Revenue
$301M
-
Net Income
$29.5M
-
Earnings per Share
$0.76
-
Free cash flow
$51M
-
EBITDA
$44.3M
-
EBITDA Ratio
0.147031
-
Total Assets
$1.5B
PEN 2-year Revenue & Income
PEN 2-year Free Cash Flow
PEN Technicals
PEN SMA
PEN RSI
FAQ
What's the current price of Penumbra (PEN) Stock?
The price of an Penumbra (PEN) share is $291.7.
What's the market cap of Penumbra?
The current market cap of Penumbra is 11.2B.
Should I buy or sell PEN?
Multiple alternative data signals suggest that Penumbra stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.
Is Penumbra a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Penumbra stock. The bullish indicators suggest that Penumbra's growth prospects and market position may lead to a positive performance in the foreseeable future.
Is now a good time to buy Penumbra (PEN) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Penumbra stock, given the bullish outlook.
What are some stocks similar to Penumbra (PEN) that investors often compare it to?
Penumbra (PEN) is often compared to similar stocks such as Abbott Laboratories, Boston Scientific, Edwards Lifesciences, Medtronic and Stryker.
What is the forecast for Penumbra's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Penumbra's stock price to be around $320.7 in 2026. Starting from the current price of $291.7, this represents a 10% change in price, indicating a bullish outlook for the stock.
How to buy Penumbra (PEN) Stock?
Penumbra stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Penumbra shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.